What are the current management guidelines for acute bronchitis and chronic bronchitis (COPD) in adults?

Current Bronchitis Management Guidelines

Acute Bronchitis

For immunocompetent adults with acute bronchitis, antibiotics should NOT be routinely prescribed, as this is a self-limiting viral illness where antibiotics provide minimal benefit (reducing cough duration by only 0.5 days) while exposing patients to unnecessary adverse effects. 1, 2

Diagnosis and Assessment

• Acute bronchitis is a clinical diagnosis characterized by acute cough (with or without sputum production) lasting approximately 2-3 weeks 2, 3
• Exclude pneumonia, asthma exacerbation, COPD exacerbation, pertussis, COVID-19, and influenza before diagnosing acute bronchitis 1, 2
• Diagnostic testing (chest x-ray, sputum culture, inflammatory markers) is not routinely indicated unless differential diagnoses are suspected 1
• The presence of green or purulent sputum does not reliably indicate bacterial infection 3
• Over 90% of acute bronchitis cases are viral in origin 3

Treatment Approach

Symptom relief and patient education are the cornerstones of management 2

• Avoid routine use of: antibiotics, antitussives, antihistamines, inhaled beta-agonists, inhaled anticholinergics, inhaled corticosteroids, oral corticosteroids, or oral NSAIDs 1, 2
• Educate patients that cough typically lasts 2-3 weeks 2
• Consider describing acute bronchitis as a "chest cold" to reduce antibiotic expectations 2

Exceptions for Antibiotic Use

Antibiotics may be considered in specific high-risk populations 4, 3:

• Immunocompromised patients 4
• Patients with chronic respiratory or cardiac diseases 4
• Elderly patients with comorbidities 4
• Suspected pertussis (to reduce transmission) 3
• Patients ≥65 years at increased risk for pneumonia 3

Follow-up

• If symptoms worsen or fail to improve, reassess and consider targeted investigations (chest x-ray, sputum culture, peak flow, CBC, CRP) 1
• Consider alternative diagnoses including asthma, as 65% of patients with recurrent "acute bronchitis" episodes may have underlying mild asthma 1

---

Chronic Bronchitis/COPD Exacerbations

For acute exacerbations of chronic bronchitis (AECB) in COPD patients, antibiotics should be prescribed when patients present with at least two of three cardinal symptoms (increased dyspnea, increased sputum volume, increased sputum purulence), with purulent sputum being one of the two symptoms. 1

Diagnosis of AECB

An exacerbation is defined by worsening from baseline with 1:

• Increased sputum purulence
• Increased sputum volume
• Increased dyspnea
• Additional symptoms: increased wheeze, chest tightness, fluid retention 1

Severity Classification (Anthonisen Criteria)

• Type I (Severe): All three cardinal symptoms present 1
• Type II (Moderate): Two of three cardinal symptoms, with purulent sputum being one 1
• Type III (Mild): One or fewer cardinal symptoms 1

Treatment Algorithm

1. Bronchodilators (ALL patients)

• Add or increase beta-agonists and/or anticholinergic drugs 1
• Inhaled route is preferred; ensure proper inhaler technique 1
• Nebulizers usually not required in outpatient setting 1

2. Antibiotics (Selective Use)

Indications for antibiotics 1:

• Type I exacerbations (all three cardinal symptoms) 1
• Type II exacerbations when purulent sputum is present 1
• Severe exacerbations requiring mechanical ventilation 1
• NOT recommended for Type III exacerbations or Type II without purulence 1

Antibiotic Selection 1, 5:

• Moderate severity: Newer macrolide, extended-spectrum cephalosporin, or doxycycline 5
• Severe exacerbations: High-dose amoxicillin-clavulanate or respiratory fluoroquinolone 5
• Risk factors for Pseudomonas (≥2 required): Recent hospitalization, frequent antibiotics (>4 courses/year or within 3 months), severe disease (FEV₁ <30%), oral steroids (>10mg prednisolone daily in last 2 weeks) 1
• If Pseudomonas risk: Ciprofloxacin or levofloxacin 750mg/24h 1

3. Oral Corticosteroids (Selective Use)

Use oral corticosteroids (30mg daily for 1 week) only when 1:

• Patient already on oral corticosteroids 1
• Previously documented response to corticosteroids 1
• Airflow obstruction fails to respond to increased bronchodilator dose 1
• First presentation of airflow obstruction 1
• Do NOT continue long-term 1

Stable COPD Management

Smoking Cessation (MOST EFFECTIVE)

• 90% of patients with chronic cough will have resolution after smoking cessation 1
• Avoidance of respiratory irritants is the most effective treatment for chronic bronchitis symptoms 1
• Benefits occur within the first year and are sustained long-term 1

Follow-up Care

Mild-to-moderate COPD (primary care) 1:

• Document COPD diagnosis and spirometry values 1
• Supervise smoking cessation 1
• Document response to each medication trial 1
• Monitor spirometry; refer if FEV₁ drops >500mL over 5 years 1

Severe COPD (shared hospital-GP care) 1:

• All recommendations for mild-moderate disease apply 1
• Monitor for long-term oxygen therapy needs 1
• Consider respiratory health worker for home visits 1

Pulmonary Rehabilitation

• Strongly recommended for adults with stable COPD (moderate-quality evidence) 1
• Strongly recommended after hospitalization for COPD exacerbation (moderate-quality evidence) 1
• Can be offered as center-based or telerehabilitation 1

Critical Pitfalls to Avoid

• Do not prescribe antibiotics for acute bronchitis in otherwise healthy adults - this is the most common error in practice 1, 2
• Do not assume green sputum equals bacterial infection requiring antibiotics 3
• Do not use antibiotics for Type III COPD exacerbations (only one cardinal symptom) 1
• Always exclude pneumonia, pneumothorax, pulmonary embolism, heart failure, and lung cancer when evaluating COPD exacerbations 1
• Do not continue oral corticosteroids long-term after AECB 1